Specifically, the α-2A adrenergic receptor (Adra2a) and associated adenylyl cyclase (AC)-cAMP activity have been shown to modulate poor executive function and neuroinflammation in depression [30, 31]. This evidence concerns the gene ADRA2A and major depressive disorder.